Topiramate

Topiramate

製品名 Topiramate
CAS番号 97240-79-4
分子式 C12H21NO8S
分子量 339.36
外観 白色の結晶性粉末
分析(HPLC) 98.0% ~ 101.0%
乾燥減量 ≤ 0.5%
焼失残渣 ≤ 0.1%
重金属 10 ppm以下
融点 125°C ~ 130°C
比回転 [α]D20 = -30.0° ~ -34.0° (c=1, methanol)

同義語

2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate, Topamax, Epitomax, Topamac, TopiLEPTIN, Topiramic acid, RWJ-17021, McN-4853

Topiramate is a sulfamate-substituted monosaccharide that functions as a broad-spectrum antiepileptic agent. It is structurally distinct from other anticonvulsants, featuring a sulfamate group attached to a fructopyranose derivative. This unique structure contributes to its multifaceted mechanism of action, which includes modulation of voltage-gated sodium channels, enhancement of GABA-A receptor activity, and inhibition of carbonic anhydrase isozymes. These actions collectively stabilize neuronal membranes and reduce excitability, making it effective in managing partial-onset and generalized seizures.

Beyond its established role in epilepsy, topiramate is widely utilized in the prophylaxis of migraine headaches and has demonstrated efficacy in weight management when combined with phentermine. Its neurostabilizing properties have also been explored in psychiatric conditions such as bipolar disorder and post-traumatic stress disorder. The compound is well-absorbed orally, exhibits linear pharmacokinetics, and has a favorable safety profile, though dose titration is recommended to minimize adverse effects like paresthesia and cognitive slowing.

機能

  • Antiepileptic Activity: Blocks voltage-dependent sodium channels and potentiates GABAergic neurotransmission, thereby suppressing abnormal neuronal firing and preventing seizure propagation.
  • Migraine Prophylaxis: Reduces cortical spreading depression and modulates trigeminal nociceptive pathways, leading to a significant decrease in migraine frequency and severity.
  • Weight Management: Inhibits carbonic anhydrase and modulates AMPA/kainate receptors, which may contribute to reduced caloric intake and increased energy expenditure, supporting its use in obesity treatment.

原産地と純度

  • 出典: Synthetic, produced via chemical synthesis from D-fructose derivatives.
  • 標準化: Assay by HPLC, typically 98.0% to 101.0% on anhydrous basis.
  • フォーム: Available as white crystalline powder; also supplied as tablets or capsules for pharmaceutical formulations.
  • 用途: Used as an active pharmaceutical ingredient (API) in the manufacture of anticonvulsant and migraine-preventive medications.

資料・供給

  • ドキュメント: COA、MSDS、TDS
  • リードタイム: 7-14 days after order confirmation.
  • パッケージ: Supplied in sealed, light-resistant containers (e.g., 1 kg, 5 kg, 25 kg) with desiccant; custom packaging available upon request.

見積依頼

  • 当社の住所: 中国陝西省西安市メインストリート280番地
  • リブバイオ株式会社. — メールアドレス: info@lyvbio.com

ぜひ連絡を

見積依頼

当社の住所

中国陝西省西安市メインストリート280番地

×